Article
Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes.
Human genetics - 1 Nov 1998
Deng H W, Li J, Li J L, Johnson M, Gong G, Davis K M, Recker R R
Abstract excerpt
Our purpose is to assess whether genotypes of the vitamin D receptor (VDR) and estrogen receptor (ER) and their interaction influence changes in bone mass in postmenopausal Caucasian women with and without hormone replacement therapy (HRT). A population of 108 US Mid-West women who participated in a study of low-dose continuous estrogen/progestin was genotyped at the VDR BsmI site and the ER XbaI and PvuII sites....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.